|
|
Volumn 300, Issue 1, 2002, Pages 91-96
|
|
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE;
ALPHA SYNUCLEIN;
ATROPINE;
BROMOCRIPTINE;
CATECHOLAMINE;
DOPAMINE 1 RECEPTOR;
FENCLONINE;
LEVODOPA;
METIROSINE;
PERGOLIDE;
SEROTONIN;
AGE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CATECHOLAMINE SYNTHESIS;
CONTROLLED STUDY;
DOPAMINERGIC NERVE CELL;
DROSOPHILA MELANOGASTER;
DRUG EFFICACY;
LOCOMOTION;
MOTOR DYSFUNCTION;
NERVE CELL DEGENERATION;
NONHUMAN;
PARKINSON DISEASE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE;
ALPHA-METHYLTYROSINE;
ALPHA-SYNUCLEIN;
ANIMALS;
ANIMALS, GENETICALLY MODIFIED;
ANTIPARKINSON AGENTS;
BROMOCRIPTINE;
DISEASE MODELS, ANIMAL;
DROSOPHILA MELANOGASTER;
GENOTYPE;
LEVODOPA;
MOTOR ACTIVITY;
MUSCULOSKELETAL EQUILIBRIUM;
NERVE TISSUE PROTEINS;
NEURONS;
PARKINSON DISEASE;
PERGOLIDE;
SYNAPSES;
SYNUCLEINS;
|
|
EID: 0036137083
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: 10.1124/jpet.300.1.91 Document Type: Article |
|
Times cited : (148)
|
|
References (19)
|
